All News

The history of targeting neuroinflammation is a good example of the challenges to finding a treatment for Alzheimer disease.

Thanks to its diverse patient population and unique culture, studying pharmacy in Hawaii provides interesting experiences with culturally competent care.

Motivational interviewing is an evidence-based method of communicating with patients who are ambivalent or resistant to change for the sake of their health.

The value proposition for point-of-care testing in the pharmacy is extensive, as pharmacies can provide a convenient, accessible, and cost-saving alternative for patients.

Mosunetuzumab showed promising results in complete response rate in patients with follicular lymphoma.

Futibatinib (Lytgobi, Taiho Oncology, Inc) is indicated for adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements.

Women Pharmacist Day takes place October 12th, 2022.

Oncology pharmacists participate significantly in conversations, research, and publications of that research.

Study results show that intravenous immunoglobulin therapy can help combat this type of PRCA in individuals with anemia.

Ronna Hauser, PharmD, and Bri Morris, PharmD, both from the National Community Pharmacists Association, discuss long-term care facilities and how they can make an impact on that patient population.

As individuals in a society, all people have implicit, or unconscious, beliefs that they have been socialized to hold; however, health care professionals’ implicit biases can impact patients’ lives.

Pharmacy Times will be spotlighting pharmacists throughout the month of October to recognize their contributions to the health care field.

October is Breast Cancer Awareness Month.

Phoenix-area Walgreens pharmacist Matthew Pruitt earns top honor as 2022 Pharmacist of the Year.

Empagliflozin has been found to lower the risk of death due to cardiovascular events and the number of first and recurrent heart failure hospitalizations.

Study results show that the frequency of adverse events decreased after the patients transitioned from combination therapy to monotherapy.

Indicated for the management of mild, moderate, and severe Alzheimer disease and dementia symptoms, the donepezil transdermal system (Adlarity; Corium) delivers donepezil hydrocholoride through the skin and is recommended at an initial dosage of 5 mg per day.

New research in immunotherapy is exploring vaccines to treat cancer, whether preventative or reactive against current tumors.

Douglas Hoey, CEO of NCPA, discusses NCPA's Annual Convention 2022, which will be held in Kansas City, Missouri from October 1 to October 4.

This month's generic product news features clorazepate dipotassium tablets, exemestane tablets, and paliperidone extended-release tablets.

Willoughby hopes on a global standpoint that every chronic condition patient has access to a support team that is there to provide care.

Belantamab mafodotin plus lenalidomide and dexamethasone was found tolerable with no new safety signals and enhanced response rates in patients with multiple myeloma.

All of the findings indicate that inadequate margin widths result in higher risks of distant recurrence and breast cancer mortality, as well as increased total recurrence.

The functional and physical well-being and other scores from the survey are more favorable for those who were treated with the therapy, investigators say.

A researcher discusses how developing tertiary lymphoid structures may reach a greater maturity level within the tumor microenvironment.

Given that dendritic cells are necessary for anti-tumor response, researchers investigated which pathways stop these cells from performing their full functions.

The incremental use of drug combinations could prevent hospitalizations from heart failure among those who have higher ejection farction, a subgroup that struggles with insufficient data on treatments.

Dupilumab is the first and only medicine approved specifically for the treatment of prurigo nodularis in the United States.